Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A global 'Common Core' framework for family medicine faculty development: Getting the right person, doing the right thing, right!

African journal of primary health care & family medicine·2026
Same author

Reconfiguring global primary care evidence: The essential role of regional journals.

South African family practice : official journal of the South African Academy of Family Practice/Primary Care·2026
Same author

Nottingham Hip Fracture Score and Acute Physiology and Chronic Health Evaluation-II: Predicting 30-day mortality in elderly hip fracture.

World journal of methodology·2026
Same author

Empowering communities against AMR: Evaluating the one health-based antibiotic-wise village (SAJAKA) in Bali, Indonesia.

Global public health·2026
Same author

Primary Care and Geography: Global Populations.

Primary care·2026
Same author

Re: Wonca Europe 2023 Definition of General Practice/Family Medicine: New Needs, New Content.

Journal of the American Board of Family Medicine : JABFM·2025

Related Experiment Video

Updated: Jun 21, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

What to do when warfarin therapy goes too far.

Shailendra Prasad1, Michael R Wootten, Nichole Kulinski

  • 1Department of Family Medicine and Community Health, University of Minnesota, Minneapolis, MN, USA. pras0054@umn.edu

The Journal of Family Practice
|July 18, 2009
PubMed
Summary

Warfarin reversal strategies depend on bleeding severity. Mild bleeding may only require withholding warfarin and oral vitamin K, while major or emergent bleeds necessitate hospitalization and clotting factor replacement.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Related Experiment Videos

Last Updated: Jun 21, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Area of Science:

  • Pharmacology
  • Hematology
  • Internal Medicine

Background:

  • Warfarin is a widely prescribed anticoagulant medication.
  • Hypocoagulability is a significant adverse effect of warfarin therapy.
  • Effective management of warfarin-induced bleeding is crucial for patient safety.

Purpose of the Study:

  • To outline optimal warfarin reversal strategies.
  • To provide guidance based on bleeding severity and International Normalized Ratio (INR).

Main Methods:

  • Review of current clinical guidelines and evidence for warfarin reversal.
  • Categorization of management approaches based on bleeding status (mild, major, emergent) and INR levels.

Main Results:

  • For mild or no bleeding with elevated INR: withhold warfarin, monitor INR; consider oral vitamin K if INR > 5.
  • For major bleeding with elevated INR: hospitalize, administer vitamin K, fresh frozen plasma, and monitor closely.
  • For emergent situations: hospitalize, administer clotting factors, and slow intravenous vitamin K infusion.

Conclusions:

  • Tailored warfarin reversal protocols are essential for managing bleeding complications.
  • Prompt and appropriate intervention based on clinical presentation improves patient outcomes.
  • Understanding different reversal options ensures effective anticoagulation management.